All Type of News
PuriMed announces Phase II clinical trial of lotus seed in depression patients
PuriMed, a local biopharmaceutical company, has recently announced the commencement of the Phase II clinical trial in patients with depression using a natural product PM011 (trade name: Lotuzol).
This control, doub...
Hyundai Pharm launches oral nicotine replacement therapyHyundai is poised to conquer the market for oral nicotine replacement therapies with Nicopass through its partnership with Pierre Fabre in France.
The company said on October...
|
Drug makers agonize over price cut of amlodipine generics
About 30 pharmaceutical firms, who are engaged in producing amlodipine maleate preparations, are attentively watching the government's final announcement on October 19, following the decision of the Health Insurance R...
Efficient investment required for regional bio-cluster plan
The government unveiled a series of ambitious measures to turn the country into an international biotechnology powerhouse over the past few years but more efficient spending for regional bio-cluster plan is needed, a...
Hospitals overcharge customers
It is strongly recommended that customers carefully check their hospital bills as some hospitals in Seoul have allegedly overcharged customers.
If your bill seems to high there's a good chance you may have been ove...
Bayer Healthcare opens web site for prevention of cardiovascular disease
Bayer Healthcare Korea said on October 10 that it has opened its health web site (www.bayer-happy100.co.kr) to prevent ever-increasing cardiovascular disease in elderly people.
Cardiovascular diseases have become ...
Daewoong launches new smokeless tobacco patchDaewoong Pharm is introducing its new smokeless tobacco patch 'Nicoman Patch' with less nicotine content from this month, following other two types nicotine troche and gum last...
|
Health ministry kicks off evaluations on large university hospitals
The Ministry of Health and Welfare announced that it will conduct the second evaluations on the nation's 85 large hospitals with 500 sickbeds between October 9 and November 30.
The evaluations will be conducted bas...
MSD Korea targets antidiabetic market
Industry watchers expect the domestic antidiabetic market is about to heat up, as MSD Korea's sitagliptin phosphate (Januvia), an oral diabetes medication in a new class of drugs known as DPP-4 inhibitors, will soon j...
Kim Ok-yeon to lead Janssen-Cilaq MalaysiaKim Ok-yeon, vice president of vice president of Johnson and Johnson Asia and Pacific marketing operation, has been named new president of Janssen-Cilaq Malaysia, according to J...
|
